Skip to main content
. 2021 Aug 1;60(15):2367–2374. doi: 10.2169/internalmedicine.6127-20

Figure 3.

Figure 3.

A linear regression analysis comparing the relative changes in the lipid profiles from baseline to six months after the administration of dapagliflozin and those in the E/e’, showing a significant correlation between changes in the HDL-C levels and those in the E/e’. HDL-C: high-density lipoprotein cholesterol